|
Richard L. Walter, Ph.D., joined Shamrock Structures as Chief Scientific Officer in July 2007. Dr. Walter is responsible for overseeing all scientific activities in structural biology R&D, enabling Shamrock to provide complete gene-to-structure services to its pharmaceutical company clients. He directs the further development of the Company’s scientific vision, laboratory operations and scientific management. He is formally trained as a protein crystallographer and protein biochemist and has over ten years industrial experience working in pharmaceutical and consumer products research. Prior to joining Shamrock in 2007, he was Associate Research Fellow at Pfizer’s Ann Arbor, Michigan Laboratories, where he had responsibility for group management and implementation of gene-to-structure capability. Prior to Pfizer, he was at The Procter & Gamble Company for nine years, where he led structural biology and protein crystallography teams in a variety of gene-to-structure projects. Dr. Walter received his Ph.D. in Biochemistry, focused in X-ray crystallography, at Cornell University in Ithaca, New York under the mentorship of Stephen E. Ealick, Ph.D. After completing his Ph.D., he was a Senior Postdoctoral Fellow at Purdue University in West Lafayette, Indiana, where he helped design, build and establish new crystallography and biochemistry laboratories. He received his B.A. in Biology/Biochemistry at the College of Wooster in Wooster, Ohio. He has published and presented extensively in the fields of structural biology and protein crystallography. | 